Vikki L. Conway is See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 1 open-market trade across 1 company since 2024, most recently 2024-05-13.
CIK 0001995297
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TEVA | 16,646 | $690K |
Shares reported on the most recent Form 4, priced at the 2024-03-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL | 2024-05-13 | 2024-05-15 | $16.74 | $510K | -0.2% | +2.2% | +2.0% |
| TEVA | SELL · 10b5-1 | 2024-03-05 | 2024-03-07 | $13.52 | $19K | -2.5% | +3.7% | +23.3% |
| TEVA | SELL · 10b5-1 | 2024-03-04 | 2024-03-05 | $13.37 | $47K | -1.1% | +2.6% | +25.0% |
| TEVA | SELL · 10b5-1 | 2024-02-28 | 2024-03-01 | $13.12 | $18K | +0.5% | +2.4% | +24.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.